Renal Cancer - Results from #1820

Everolimus or sunitinib as first-line treatment of metastatic papillary renal cell carcinoma: A retrospective study of the GETUG group (Groupe d'Etude des Tumeurs Uro-Génitales). October 11, 2021

Characterizing the tumor microenvironment in rare renal cancer histological types. October 8, 2021

Identification of Prognostic Metabolism-Related Genes in Clear Cell Renal Cell Carcinoma. October 8, 2021

Metastasectomy in kidney cancer: current indications and treatment approaches. October 7, 2021

Parenchymal Volume Replacement by Renal Cell Carcinoma Prior to Intervention: Predictive Factors and Functional Implications. October 7, 2021

Renal cell carcinoma with unusual metachronous metastasis up to 22 years after nephrectomy: two case reports. October 7, 2021

Treatment-free survival after discontinuation of immune checkpoint inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysis. October 6, 2021

Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study. October 6, 2021

Nobel Winner Dr. James P. “Jim” Allison to Give Keynote Address at IKCS 2021 October 5, 2021

Inflammatory response markers and survival prediction in patients with renal cell carcinoma. October 5, 2021

CD44 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma. October 5, 2021

Limited Association Between Ascorbate Concentrations and Vitamin C Transporters in Renal Cell Carcinoma Cells and Clinical Samples. October 4, 2021

Morphomics Can Predict Oncological Features and Survival of Metastatic Renal Cell Carcinoma After Cytoreductive Nephrectomy. October 4, 2021

Predictive radiomics signature for treatment response to nivolumab in patients with advanced renal cell carcinoma. October 1, 2021

Eosinophilic features in clear cell renal cell carcinoma correlate with outcomes of immune checkpoint and angiogenesis blockade. October 1, 2021

Evaluation of the association of health care system access with kidney cancer surgical outcomes for hispanic and non-hispanic white patients. September 30, 2021

Somatic mutations as preoperative predictors of metastases in patients with localized clear cell renal cell carcinoma - An exploratory analysis. September 30, 2021

Early detection of kidney cancer using urinary proteins: a truly non-invasive strategy. September 29, 2021

Use of Second-line Immunotherapy in Control Arms of Randomized Clinical Trials in Kidney Cancer: A Systematic Review. September 29, 2021

Overexpression of IRF3 Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma. September 28, 2021

Page 92 of 456